Download integrale PDF - Progetto Mondiale Asma - Ginasma

210. Wechsler ME, Pauwels R, Drazen JM. Leukotriene
modifiers and Churg-Strauss syndrome: adverse effect
or response to corticosteroid withdrawal?
Drug Saf 1999; 21: 241-51.
211. Wechsler ME, Finn D, Gunawardena D, Westlake R,
Barker A, Haranath SP, et al. Churg-Strauss syndrome
in patients receiving montelukast as treatment for
asthma. Chest 2000; 117: 708-13.
212. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome.
Lancet. 2003; 361: 587-94. Review. 213. Rafferty P,
Jackson L, Smith R, Holgate ST. Terfenadine, a potent
histamine H1-receptor antagonist in the treatment of
grass pollen sensitive asthma.
Br J Clin Pharmacol 1990; 30: 229-35.
214. Dijkman JH, Hekking PR, Molkenboer JF, Nierop G,
Vanderschueren R, Bernheim J, et al. Prophylactic
treatment of grass pollen-induced asthma with cetirizine.
Clin Exp Allergy 1990; 20: 483-90.
215. Grant JA, Nicodemus CF, Findlay SR, Glovsky MM,
Grossman J, Kaiser H, et al. Cetirizine in patients with
seasonal rhinitis and concomitant asthma: prospective,
randomized, placebo-controlled trial.
J Allergy Clin Immunol 1995; 95: 923-32.
216. Kurosawa M. Anti-allergic drug use in Japan–the
rationale and the clinical outcome.
Clin Exp Allergy 1994; 24: 299-306.
217. Hill JM, Tattersfield AE. Corticosteroid sparing agents in
asthma.
Thorax 1995; 50: 577-82.
218. Shiner RJ, Nunn AJ, Chung KF, Geddes DM.
Randomised, double-blind, placebo-controlled trial of
methotrexate in steroid-dependent asthma.
Lancet 1990; 336: 137-40.
219. Mullarkey MF, Lammert JK, Blumenstein BA. Longterm
methotrexate treatment in corticosteroiddependent
asthma.
Ann Intern Med 1990; 112: 577-81.
220. Davies H, Olson L, Gibson P. Methotrexate as a steroid
sparing agent for asthma in adults.
Cochrane Database Syst Rev 2000; 2.
221. Lock SH, Kay AB, Barnes NC. Double-blind, placebocontrolled
study of cyclosporin A as a corticosteroidsparing
agent in corticosteroid-dependent asthma.
Am J Respir Crit Care Med 1996; 153: 509-14.
222. Bernstein IL, Bernstein DI, Dubb JW, Faiferman I,
Wallin B. A placebo-controlled multicenter study of
auranofin in the treatment of patients with
corticosteroiddependent asthma. Auranofin Multicenter
Drug Trial.
J Allergy Clin Immunol 1996; 98: 317-24.
223. Nierop G, Gijzel WP, Bel EH, Zwinderman AH, Dijkman
JH. Auranofin in the treatment of steroid dependent
asthma: a double blind study.
Thorax 1992; 47: 349-54.
224. Aaron SD, Dales RE, Pham B. Management of steroiddependent
asthma with methotrexate: a meta-analysis of
randomized clinical trials.
Respir Med 1998; 92: 1059-65.
225. Marin MG. Low-dose methotrexate spares steroid usage
in steroid-dependent asthmatic patients: a metaanalysis.
Chest 1997; 112: 29-33.
226. Kishiyama JL, Valacer D, Cunningham-Rundles C,
Sperber K, Richmond GW, Abramson S, et al. A
multicenter, randomized, double-blind, placebocontrolled
trial of high-dose intravenous immunoglobulin for oral
corticosteroid-dependent asthma.
Clin Immunol 1999; 91: 126-33.
227. Salmun LM, Barlan I, Wolf HM, Eibl M, Twarog FJ,
Geha RS, et al. Effect of intravenous immunoglobulin on
steroid consumption in patients with severe asthma: a
double-blind, placebo-controlled, randomized trial.
J Allergy Clin Immunol 1999; 103: 810-5.
228. Jakobsson T, Croner S, Kjellman NI, Pettersson A,
Vassella C, Bjorksten B. Slight steroid-sparing effect of
intravenous immunoglobulin in children and adolescents
with moderately severe bronchial asthma.
Allergy 1994; 49: 413-20.
229. Kamada AK, Hill MR, Ikle DN, Brenner AM, Szefler SJ.
Efficacy and safety of low-dose troleandomycin therapy
in children with severe, steroid-requiring asthma.
J Allergy Clin Immunol 1993; 91: 873-82.
230. Siracusa A, Brugnami G, Fiordi T, Areni S, Severini C,
Marabini A. Troleandomycin in the treatment of difficult
asthma. J Allergy Clin Immunol 1993; 92: 677-82.
231. Bonifazi F, Bilò MB. Efficacy of specific immunotherapy
in allergic asthma: myth or reality?
Allergy. 1997; 52: 698-710.
232. Passalacqua G, Canonica GW. Long lasting efficacy of
specific immunotherapy. Allergy 2002; 57: 275-6.
233. Moller E, Dreborg S, Ferdousi HA et al. Pollen
immunotherapy reduces the development of asthma in
children with seasonal rhinoconjunctivitis (the PATstudy).
J Allergy Clin Immunol. 2002; 109: 251-6.
234. Canonica GW, Passalacqua G. Noninjection routes of
Immunotherapy.
J Allergy Clin Immunol 2003; 111: 437-48.
235. Durham SR, Till SJ. Immunological changes associated
with allergen immunotherapy.
J Allergy Clin Immunol 1998; 102: 157-165.
PROGRAMMA DI TRATTAMENTO DELL’ASMA IN SEI PARTI 163